Immunotech Laboratories Stock Performance

IMMB Stock  USD 0.0002  0.0001  100.00%   
Immunotech Laboratories holds a performance score of 10 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -1.65, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Immunotech Laboratories are expected to decrease by larger amounts. On the other hand, during market turmoil, Immunotech Laboratories is expected to outperform it. Use Immunotech Laboratories total risk alpha, as well as the relationship between the daily balance of power and day typical price , to analyze future returns on Immunotech Laboratories.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Immunotech Laboratories are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile primary indicators, Immunotech Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:100
Last Split Date
2009-02-26
1
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering - GlobeNewswire
01/23/2026
2
12 Health Care Stocks Moving In Fridays After-Market Session - Benzinga
02/13/2026

Immunotech Laboratories Relative Risk vs. Return Landscape

If you would invest  0.01  in Immunotech Laboratories on November 30, 2025 and sell it today you would earn a total of  0.01  from holding Immunotech Laboratories or generate 100.0% return on investment over 90 days. Immunotech Laboratories is currently generating 1.5873% in daily expected returns and assumes 12.5988% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Immunotech, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Immunotech Laboratories is expected to generate 16.61 times more return on investment than the market. However, the company is 16.61 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Immunotech Laboratories Target Price Odds to finish over Current Price

The tendency of Immunotech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0002 90 days 0.0002 
near 1
Based on a normal probability distribution, the odds of Immunotech Laboratories to move above the current price in 90 days from now is near 1 (This Immunotech Laboratories probability density function shows the probability of Immunotech Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Immunotech Laboratories has a beta of -1.65. This usually indicates as returns on its benchmark rise, returns on holding Immunotech Laboratories are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Immunotech Laboratories is expected to outperform its benchmark. Moreover Immunotech Laboratories has an alpha of 1.637, implying that it can generate a 1.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Immunotech Laboratories Price Density   
       Price  

Predictive Modules for Immunotech Laboratories

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunotech Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.000112.60
Details
Intrinsic
Valuation
LowRealHigh
0.000.000112.60
Details
Naive
Forecast
LowNextHigh
0.0000050.000212.60
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00020.00020.0002
Details

Immunotech Laboratories Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Immunotech Laboratories is not an exception. The market had few large corrections towards the Immunotech Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immunotech Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immunotech Laboratories within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.64
β
Beta against Dow Jones-1.65
σ
Overall volatility
0.000031
Ir
Information ratio 0.12

Immunotech Laboratories Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immunotech Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immunotech Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Immunotech Laboratories is way too risky over 90 days horizon
Immunotech Laboratories has some characteristics of a very speculative penny stock
Immunotech Laboratories appears to be risky and price may revert if volatility continues
Net Loss for the year was (977.57 K) with profit before overhead, payroll, taxes, and interest of 0.
Immunotech Laboratories has a very weak financial position based on the latest SEC disclosures
Latest headline from news.google.com: 12 Health Care Stocks Moving In Fridays After-Market Session - Benzinga

Immunotech Laboratories Fundamentals Growth

Immunotech Stock prices reflect investors' perceptions of the future prospects and financial health of Immunotech Laboratories, and Immunotech Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immunotech Stock performance.

About Immunotech Laboratories Performance

By analyzing Immunotech Laboratories' fundamental ratios, stakeholders can gain valuable insights into Immunotech Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Immunotech Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Immunotech Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.09)(1.15)
Return On Capital Employed(0.08)(0.08)
Return On Assets(0.05)(0.06)
Return On Equity(0.09)(0.09)

Things to note about Immunotech Laboratories performance evaluation

Checking the ongoing alerts about Immunotech Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immunotech Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Immunotech Laboratories is way too risky over 90 days horizon
Immunotech Laboratories has some characteristics of a very speculative penny stock
Immunotech Laboratories appears to be risky and price may revert if volatility continues
Net Loss for the year was (977.57 K) with profit before overhead, payroll, taxes, and interest of 0.
Immunotech Laboratories has a very weak financial position based on the latest SEC disclosures
Latest headline from news.google.com: 12 Health Care Stocks Moving In Fridays After-Market Session - Benzinga
Evaluating Immunotech Laboratories' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Immunotech Laboratories' stock performance include:
  • Analyzing Immunotech Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immunotech Laboratories' stock is overvalued or undervalued compared to its peers.
  • Examining Immunotech Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Immunotech Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immunotech Laboratories' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Immunotech Laboratories' stock. These opinions can provide insight into Immunotech Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Immunotech Laboratories' stock performance is not an exact science, and many factors can impact Immunotech Laboratories' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Immunotech Stock analysis

When running Immunotech Laboratories' price analysis, check to measure Immunotech Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunotech Laboratories is operating at the current time. Most of Immunotech Laboratories' value examination focuses on studying past and present price action to predict the probability of Immunotech Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunotech Laboratories' price. Additionally, you may evaluate how the addition of Immunotech Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account